丙肝临床试验招募信息（全球在招）

这里汇总了全球正在招募患者的 丙肝（国际通用名 hepatitis C）新药临床试验，包含试验分期、招募状态、开展国家和研究团队联系方式，全部以中文呈现。数据实时来自全球最大的临床试验注册库 ClinicalTrials.gov。本页同时覆盖丙型肝炎等说法。

正在招募的丙肝新药试验

• Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer

  不适用招募中英国NCT06658782

• Drug-Drug Intercations and Direct Acting Antiviral Agents Against HCV

  不适用招募中西班牙NCT06928259

• California MEPS Hub

  不适用招募中美国NCT07433985

• The Efficacy of Vosevi in Treating DAA-experienced Patients

  不适用招募中中国NCT06180590

• Hepatitis C Pharmacist, Physician, Patient Navigator Collaborative Care Model in Permanent Supportive Housing

  不适用招募中美国NCT07667101

• Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data

  不适用招募中加拿大NCT07419347

• Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder

  II 期 / III 期招募中美国NCT05637879

• Implementing Low-Barrier HCV Treatment in a Jail Setting

  IV 期招募中美国NCT06953479

• Feasibility and Acceptability of HCV Treatment in Pregnancy

  不适用招募中美国NCT06367465

• Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening

  不适用招募中美国NCT06745895

• The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset

  不适用招募中澳大利亚NCT05713136

• Effect of Some Drugs on Liver Fibrosis

  III 期招募中EgyptNCT03770936